Monopar Therapeutics (MNPR) Shares Outstanding (Entity) (2017 - 2026)
Monopar Therapeutics (MNPR) reported Shares Outstanding (Entity) of 8.54 million for Q2 2026, up 39.4% from 6.13 million a year earlier.
Powered by 
Analysis
Monopar Therapeutics (MNPR) Shares Outstanding (Entity) (2017 - 2026) Analysis & Trends
For FY2025, Monopar Therapeutics posted Shares Outstanding (Entity) of 6.69 million, up 76.6% from FY2024.
- Shares Outstanding (Entity) has increased for seven consecutive years, with a five-year compound annual growth rate of 23.9% (FY2020 to FY2025).
- By year, Shares Outstanding (Entity) came in at 3.79 million in FY2024 (+27.1%), 2.98 million in FY2023 (+15.1%), 2.59 million in FY2022 (+2.8%) and 2.52 million in FY2021 (+10.0%).
- The Q2 2026 figure ranks as the highest quarterly Shares Outstanding (Entity) in data going back to Q1 2017.
- The year-over-year growth in Shares Outstanding (Entity) has ranged between 0.4% (Q1 2022) and 89.0% (Q3 2025) over the last five years.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 2.41 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 540.60 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.24 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 5.70 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 253.35 Mn |
| 10 | Monopar Therapeutics | 680.58 Mn | 398.81 Mn | - | 8.54 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.54 Mn |
| Dec 31, 2025 | 6.69 Mn |
| Sep 30, 2025 | 6.66 Mn |
| Jun 30, 2025 | 6.13 Mn |
| Mar 31, 2025 | 6.12 Mn |
| Dec 31, 2024 | 3.79 Mn |
| Sep 30, 2024 | 3.53 Mn |
| Jun 30, 2024 | 3.52 Mn |
| Mar 31, 2024 | 3.50 Mn |
| Dec 31, 2023 | 2.98 Mn |
| Sep 30, 2023 | 2.84 Mn |
| Jun 30, 2023 | 2.78 Mn |
| Mar 31, 2023 | 2.64 Mn |
| Dec 31, 2022 | 2.59 Mn |
| Sep 30, 2022 | 2.57 Mn |
| Jun 30, 2022 | 2.54 Mn |
| Mar 31, 2022 | 2.52 Mn |
| Dec 31, 2021 | 2.52 Mn |
| Sep 30, 2021 | 2.52 Mn |
| Jun 30, 2021 | 2.52 Mn |
API Access
Monopar Therapeutics Shares Outstanding (Entity) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=MNPR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-entity", "ticker": "MNPR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=MNPR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();